799 related articles for article (PubMed ID: 30586714)
1. Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension.
Hautefort A; Mendes-Ferreira P; Sabourin J; Manaud G; Bertero T; Rucker-Martin C; Riou M; Adão R; Manoury B; Lambert M; Boet A; Lecerf F; Domergue V; Brás-Silva C; Gomez AM; Montani D; Girerd B; Humbert M; Antigny F; Perros F
Circulation; 2019 Feb; 139(7):932-948. PubMed ID: 30586714
[TBL] [Abstract][Full Text] [Related]
2. Codependence of Bone Morphogenetic Protein Receptor 2 and Transforming Growth Factor-β in Elastic Fiber Assembly and Its Perturbation in Pulmonary Arterial Hypertension.
Tojais NF; Cao A; Lai YJ; Wang L; Chen PI; Alcazar MAA; de Jesus Perez VA; Hopper RK; Rhodes CJ; Bill MA; Sakai LY; Rabinovitch M
Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1559-1569. PubMed ID: 28619995
[TBL] [Abstract][Full Text] [Related]
3. Phenotypically Silent Bone Morphogenetic Protein Receptor 2 Mutations Predispose Rats to Inflammation-Induced Pulmonary Arterial Hypertension by Enhancing the Risk for Neointimal Transformation.
Tian W; Jiang X; Sung YK; Shuffle E; Wu TH; Kao PN; Tu AB; Dorfmüller P; Cao A; Wang L; Peng G; Kim Y; Zhang P; Chappell J; Pasupneti S; Dahms P; Maguire P; Chaib H; Zamanian R; Peters-Golden M; Snyder MP; Voelkel NF; Humbert M; Rabinovitch M; Nicolls MR
Circulation; 2019 Oct; 140(17):1409-1425. PubMed ID: 31462075
[TBL] [Abstract][Full Text] [Related]
4. Loss of KCNK3 is a hallmark of RV hypertrophy/dysfunction associated with pulmonary hypertension.
Lambert M; Boet A; Rucker-Martin C; Mendes-Ferreira P; Capuano V; Hatem S; Adão R; Brás-Silva C; Hautefort A; Michel JB; Dorfmuller P; Fadel E; Kotsimbos T; Price L; Jourdon P; Montani D; Humbert M; Perros F; Antigny F
Cardiovasc Res; 2018 May; 114(6):880-893. PubMed ID: 29360952
[TBL] [Abstract][Full Text] [Related]
5. Characterization of
Lambert M; Capuano V; Boet A; Tesson L; Bertero T; Nakhleh MK; Remy S; Anegon I; Pechoux C; Hautefort A; Rucker-Martin C; Manoury B; Domergue V; Mercier O; Girerd B; Montani D; Perros F; Humbert M; Antigny F
Circ Res; 2019 Sep; 125(7):678-695. PubMed ID: 31347976
[TBL] [Abstract][Full Text] [Related]
6. Potassium Channel Subfamily K Member 3 (KCNK3) Contributes to the Development of Pulmonary Arterial Hypertension.
Antigny F; Hautefort A; Meloche J; Belacel-Ouari M; Manoury B; Rucker-Martin C; Péchoux C; Potus F; Nadeau V; Tremblay E; Ruffenach G; Bourgeois A; Dorfmüller P; Breuils-Bonnet S; Fadel E; Ranchoux B; Jourdon P; Girerd B; Montani D; Provencher S; Bonnet S; Simonneau G; Humbert M; Perros F
Circulation; 2016 Apr; 133(14):1371-85. PubMed ID: 26912814
[TBL] [Abstract][Full Text] [Related]
7. Dysregulated Smooth Muscle Cell BMPR2-ARRB2 Axis Causes Pulmonary Hypertension.
Wang L; Moonen JR; Cao A; Isobe S; Li CG; Tojais NF; Taylor S; Marciano DP; Chen PI; Gu M; Li D; Harper RL; El-Bizri N; Kim YM; Stankunas K; Rabinovitch M
Circ Res; 2023 Mar; 132(5):545-564. PubMed ID: 36744494
[TBL] [Abstract][Full Text] [Related]
8. Critical role for the advanced glycation end-products receptor in pulmonary arterial hypertension etiology.
Meloche J; Courchesne A; Barrier M; Carter S; Bisserier M; Paulin R; Lauzon-Joset JF; Breuils-Bonnet S; Tremblay É; Biardel S; Racine C; Courture C; Bonnet P; Majka SM; Deshaies Y; Picard F; Provencher S; Bonnet S
J Am Heart Assoc; 2013 Jan; 2(1):e005157. PubMed ID: 23525442
[TBL] [Abstract][Full Text] [Related]
9. Single-cell RNA sequencing reveals that
Du M; Jiang H; Liu H; Zhao X; Zhou Y; Zhou F; Piao C; Xu G; Ma F; Wang J; Perros F; Morrell NW; Gu H; Yang J
Eur Respir J; 2022 Jul; 60(1):. PubMed ID: 34857612
[TBL] [Abstract][Full Text] [Related]
10. BMPR2 gene delivery reduces mutation-related PAH and counteracts TGF-β-mediated pulmonary cell signalling.
Feng F; Harper RL; Reynolds PN
Respirology; 2016 Apr; 21(3):526-32. PubMed ID: 26689975
[TBL] [Abstract][Full Text] [Related]
11. CCL5 deficiency rescues pulmonary vascular dysfunction, and reverses pulmonary hypertension via caveolin-1-dependent BMPR2 activation.
Nie X; Tan J; Dai Y; Liu Y; Zou J; Sun J; Ye S; Shen C; Fan L; Chen J; Bian JS
J Mol Cell Cardiol; 2018 Mar; 116():41-56. PubMed ID: 29374556
[TBL] [Abstract][Full Text] [Related]
12. BMP type II receptor as a therapeutic target in pulmonary arterial hypertension.
Orriols M; Gomez-Puerto MC; Ten Dijke P
Cell Mol Life Sci; 2017 Aug; 74(16):2979-2995. PubMed ID: 28447104
[TBL] [Abstract][Full Text] [Related]
13. Genetic ablation of the BMPR2 gene in pulmonary endothelium is sufficient to predispose to pulmonary arterial hypertension.
Hong KH; Lee YJ; Lee E; Park SO; Han C; Beppu H; Li E; Raizada MK; Bloch KD; Oh SP
Circulation; 2008 Aug; 118(7):722-30. PubMed ID: 18663089
[TBL] [Abstract][Full Text] [Related]
14. Autophagy contributes to BMP type 2 receptor degradation and development of pulmonary arterial hypertension.
Gomez-Puerto MC; van Zuijen I; Huang CJ; Szulcek R; Pan X; van Dinther MA; Kurakula K; Wiesmeijer CC; Goumans MJ; Bogaard HJ; Morrell NW; Rana AA; Ten Dijke P
J Pathol; 2019 Nov; 249(3):356-367. PubMed ID: 31257577
[TBL] [Abstract][Full Text] [Related]
15. CRISPR-mediated Bmpr2 point mutation exacerbates late pulmonary vasculopathy and reduces survival in rats with experimental pulmonary hypertension.
Kabwe JC; Sawada H; Mitani Y; Oshita H; Tsuboya N; Zhang E; Maruyama J; Miyasaka Y; Ko H; Oya K; Ito H; Yodoya N; Otsuki S; Ohashi H; Okamoto R; Dohi K; Nishimura Y; Mashimo T; Hirayama M; Maruyama K
Respir Res; 2022 Apr; 23(1):87. PubMed ID: 35395852
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic Characterization of
Hadinnapola C; Bleda M; Haimel M; Screaton N; Swift A; Dorfmüller P; Preston SD; Southwood M; Hernandez-Sanchez J; Martin J; Treacy C; Yates K; Bogaard H; Church C; Coghlan G; Condliffe R; Corris PA; Gibbs S; Girerd B; Holden S; Humbert M; Kiely DG; Lawrie A; Machado R; MacKenzie Ross R; Moledina S; Montani D; Newnham M; Peacock A; Pepke-Zaba J; Rayner-Matthews P; Shamardina O; Soubrier F; Southgate L; Suntharalingam J; Toshner M; Trembath R; Vonk Noordegraaf A; Wilkins MR; Wort SJ; Wharton J; ; Gräf S; Morrell NW
Circulation; 2017 Nov; 136(21):2022-2033. PubMed ID: 28972005
[TBL] [Abstract][Full Text] [Related]
17. Rho-kinase inhibition alleviates pulmonary hypertension in transgenic mice expressing a dominant-negative type II bone morphogenetic protein receptor gene.
Yasuda T; Tada Y; Tanabe N; Tatsumi K; West J
Am J Physiol Lung Cell Mol Physiol; 2011 Nov; 301(5):L667-74. PubMed ID: 21856816
[TBL] [Abstract][Full Text] [Related]
18. Endothelin-Bone morphogenetic protein type 2 receptor interaction induces pulmonary artery smooth muscle cell hyperplasia in pulmonary arterial hypertension.
Maruyama H; Dewachter C; Belhaj A; Rondelet B; Sakai S; Remmelink M; Vachiery JL; Naeije R; Dewachter L
J Heart Lung Transplant; 2015 Mar; 34(3):468-78. PubMed ID: 25447587
[TBL] [Abstract][Full Text] [Related]
19. EIF2AK4 mutation as "second hit" in hereditary pulmonary arterial hypertension.
Eichstaedt CA; Song J; Benjamin N; Harutyunova S; Fischer C; Grünig E; Hinderhofer K
Respir Res; 2016 Nov; 17(1):141. PubMed ID: 27809840
[TBL] [Abstract][Full Text] [Related]
20. Crosstalk between BMP signaling and KCNK3 in phenotypic switching of pulmonary vascular smooth muscle cells.
Yeo Y; Jeong H; Kim M; Choi Y; Kim KL; Suh W
BMB Rep; 2022 Nov; 55(11):565-570. PubMed ID: 36016502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
